cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Catalyst Pharmaceuticals Inc
11 own
30 watching
Current Price
$15.99
$-0.74
(-4.42%)
logo-cprx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,663.99M
52-Week High
52-Week High
22.11
52-Week Low
52-Week Low
5.24
Average Volume
Average Volume
3M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
9.1246
iconMarket Capitalization1,663.99M
icon52-Week High22.11
icon52-Week Low5.24
iconAverage Volume3M
iconDividend Yield--
iconP/E Ratio9.1246
What does the Catalyst Pharmaceuticals Inc do?
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Read More
How much money does Catalyst Pharmaceuticals Inc make?
News & Events about Catalyst Pharmaceuticals Inc.
Globe Newswire
2days ago
Strengthens its Commercial Portfolio with the First and Only AMPA Receptor Antagonist Marketed Product for Epilepsy Bolsters Presence in Neuroscience Expected to be Accretive in 2023 CORAL GABLES, Fla., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a ...
Globe Newswire
4days ago
Announced Earlier Today-Notice Received from ANDA Filer for FIRDAPSE CORAL GABLES, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc.("Catalyst") (NASDAQ: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines ...
Globe Newswire
4days ago
CORAL GABLES, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced that it has ...
Globe Newswire
2 months ago
CORAL GABLES, Fla., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc.("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced that it has ...
Globe Newswire
3 months ago
Conference Call and Webcast to be held on November 10, 2022, at 8:30 AM ETCORAL GABLES, Fla., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc.("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel ...
Frequently Asked Questions
Frequently Asked Questions
What is Catalyst Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Catalyst Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Catalyst Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Catalyst Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Catalyst Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Catalyst Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Catalyst Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Catalyst Pharmaceuticals Inc?
plus_minus_icon
What percentage is Catalyst Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Catalyst Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$15.99
$-0.74
(-4.42%)
logo-cprx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00